A drug widely used to treat Type 2 diabetes may have unintended effects on the pancreas that could lead to a form of low-grade pancreatitis in some patients and a greater risk of pancreatic cancer in long-term users, UCLA researchers have found.
Archive for April, 2009
Popular diabetes treatment could trigger pancreatitis, pancreatic cancer (PhysOrg)
Published April 30th, 2009 in Osteosarcoma News. 0 CommentsTeams walk 24-hours to raise money for cancer society (Hi-Desert Star)
Published April 30th, 2009 in Osteosarcoma News. 0 CommentsYUCCA VALLEY — Over 500 walkers, runners and rollers raised $115,000 for the American Cancer Society at the Morongo Basin’s Relay For Life Saturday and Sunday on the Yucca Valley High School football field.
Study bolsters hopes for prostate cancer vaccine rejected by FDA (Baltimore Sun)
Published April 30th, 2009 in Osteosarcoma News. 0 CommentsThe vaccine, Provenge, extended life an average of four months, nearly twice as long as the best available chemotherapy, researchers say. A controversial prostate cancer vaccine that previously had been rejected by the Food and Drug Administration improves survival of patients with the advanced form of the disease more than existing treatments and should be brought to market, researchers said …
First Ever Prospective Fracture Study In Prostate Cancer Patients On ADT Reveals These Men Are At High Risk For … (Medical News Today)
Published April 29th, 2009 in Osteosarcoma News. 0 CommentsGTx, Inc.
Prostate cancer therapy increases risk of fractures and cardiovascular-related death (News-Medical-Net)
Published April 29th, 2009 in Osteosarcoma News. 0 CommentsProstate cancer patients who undergo therapy to decrease testosterone levels increase their risk of developing bone- and heart-related side effects compared to patients who do not take these medications, according to a new analysis.
Recent Comments